SNSE Stock Summary and Trading Ideas (Sensei Biotherapeutics | NASDAQ:SNSE)

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

Sensei Biotherapeutics trades on the NASDAQ stock market under the symbol SNSE.

As of December 4, 2025, SNSE stock price climbed to $10.56 with 35,584 million shares trading.

SNSE has a beta of 1.85, meaning it tends to be more sensitive to market movements. SNSE has a correlation of 0.10 to the broad based SPY ETF.

SNSE has a market cap of $13.31 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, SNSE traded as high as $38.80 and as low as $5.00.

The top ETF exchange traded funds that SNSE belongs to (by Net Assets): VXF, DFSU.

SNSE has underperformed the market in the last year with a return of +2.9%, while SPY returned +14.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in SNSE shares. However, SNSE has outperformed the market in the last 3 month and 2 week periods, returning +21.7% and +5.4%, while SPY returned +6.6% and +3.3%, respectively. This indicates SNSE has been having a stronger performance recently.

SNSE support price is $7.99 and resistance is $9.41 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SNSE shares will trade within this expected range on the day.